Investor Overview

Investor Presentation
Financial News
Sep 17, 2019

Medicenna Therapeutics Corp. ("Medicenna" or "the Company") (TSX: MDNA, OTCQB: MDNAF), a clinical stage immuno-oncology company, today announced that it will present an update on the lead...

Sep 12, 2019

Medicenna Therapeutics Corp. ("Medicenna" or "the Company") (TSX: MDNA, OTCQB: MDNAF), a clinical stage immuno-oncology company, today announced that it will present updated clinical results from...

Stock Quote
TSXMDNA
Stock Chart
TSXMDNA
Upcoming Events
Wednesday, September 25, 2019 - Saturday, September 28, 2019

Title: Long-acting MDNA109: Emerging IL-2 Superkines displaying potent anti-tumoral responses. Presenter: Dr. Minh To, Ph.D. Poster #: B042 Date/Time: Friday, September 27th, 2019 from 1:00-3:00pm...

Investor Contact
For more investor information, Please contact:
 
Elizabeth Williams, Chief Financial Officer
 
 
Email Alerts
* Required Fields